The notices it replaced
Its page names no earlier notice: it is new, or it does not say.
Replaced by RFA-HL-23-007.
Who won it before
Competing awards, new and renewals, since FY2014, under this notice and the notices it replaced.
- Past awards
- 6
- 6 new
- Median first-year cost
- $112,693
- $678,197 in all
- Institutions
- 3
- 6 contact PIs
Awards by fiscal year
0
0
0
0
0
0
2
2
2
0
0
0
0
14151617181920212223242526
Fiscal years 2014 to 2026.
Most frequent institutions
- UNIVERSITY OF CALIFORNIA, SAN FRANCISCO4
- EMORY UNIVERSITY1
- UNIVERSITY OF CALIFORNIA LOS ANGELES1
Most frequent study sections
- Special Emphasis Panel (ZHL1 CSR-S (M1))2
- Special Emphasis Panel (ZHL1 CSR-Z (M2))2
- Special Emphasis Panel (ZAI1 ESB-M (M1))1
- Special Emphasis Panel (ZHL1 CSR-I (M1))1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| FY2022 | Using Machine Learning and Patient-Reported Outcomes to Identify Unnecessary Hospitalizations1K38HL164955-01 | Leuchter, Richard K | UNIVERSITY OF CALIFORNIA LOS ANGELES, CA | First-year cost $111,866 | Study section ZHL1 |
| FY2022 | Control of ribosomal function in cells of the hematopoietic system1K38HL165490-01 | Levine, Andrew | UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, CA | First-year cost $111,089 | Study section ZHL1 |
| FY2021 | Deep learning tools for the automated analysis of hematopathology whole slide images and the development of prognostic algorithms for hematopoietic stem cell transplant recipients1K38HL159128-01 | Goldgof, Gregory Mark | UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, CA | First-year cost $119,318 | Study section ZHL1 |
| FY2021 | Systems Biology Approach to SARS-CoV-2 Infection in Individuals with known COVID-19 Contacts: A Prospective Cohort Study1K38AI163480-01 | Scanlon, Nicholas | EMORY UNIVERSITY, GA | First-year cost $108,886 | Study section ZAI1 |
| FY2020 | Host-parasite lipid metabolism in Trypanosoma cruzi-infected cardiac myocytes1K38HL154203-01 | Whitman, Jeffrey Dominick | UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, CA | First-year cost $113,519 | Study section ZHL1 |
| FY2020 | The Role of PPARgamma in Th2 cells and Obesity-Associated Asthma.1K38HL154202-01 | Bapat, Sagar Pradeep | UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, CA | First-year cost $113,519 | Study section ZHL1 |
Newest fiscal year first, then first-year cost.
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-13-0.3.2. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.